| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,512 |
25,076 |
$4.41M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
19,473 |
16,567 |
$3.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,827 |
26,105 |
$3.14M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,147 |
3,661 |
$2.28M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,453 |
5,029 |
$854K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,832 |
3,239 |
$597K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,513 |
1,335 |
$564K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,861 |
5,478 |
$428K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
6,422 |
5,768 |
$424K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,046 |
5,931 |
$389K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,399 |
12,223 |
$389K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,459 |
1,257 |
$345K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,707 |
15,052 |
$329K |
| 80053 |
Comprehensive metabolic panel |
42,964 |
35,181 |
$325K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,912 |
7,097 |
$309K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
47,246 |
38,285 |
$305K |
| 71045 |
Radiologic examination, chest; single view |
10,482 |
9,040 |
$233K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,345 |
1,112 |
$205K |
| 71046 |
Radiologic examination, chest; 2 views |
5,108 |
4,607 |
$187K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
496 |
452 |
$181K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,386 |
3,949 |
$132K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,386 |
3,949 |
$132K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,564 |
5,719 |
$114K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,407 |
4,610 |
$109K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
976 |
893 |
$107K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,898 |
1,571 |
$95K |
| 84484 |
|
13,757 |
8,248 |
$94K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,276 |
1,361 |
$86K |
| 36415 |
Collection of venous blood by venipuncture |
44,476 |
35,261 |
$80K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
257 |
227 |
$77K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
195 |
187 |
$76K |
| 73630 |
|
1,600 |
1,419 |
$76K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
965 |
820 |
$75K |
| 76801 |
|
811 |
651 |
$73K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,972 |
1,807 |
$70K |
| 73610 |
|
1,259 |
1,131 |
$66K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,427 |
1,492 |
$63K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,481 |
577 |
$62K |
| 0240U |
|
428 |
388 |
$60K |
| 81001 |
|
18,731 |
15,888 |
$59K |
| 81025 |
|
7,925 |
6,978 |
$58K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,373 |
1,261 |
$58K |
| 87400 |
|
4,135 |
2,575 |
$58K |
| 83690 |
|
8,299 |
7,150 |
$55K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
139 |
92 |
$51K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,153 |
7,524 |
$49K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,135 |
981 |
$47K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,031 |
6,932 |
$44K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,378 |
4,706 |
$44K |
| 83735 |
|
7,738 |
6,571 |
$42K |
| 73130 |
|
841 |
740 |
$40K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,236 |
1,857 |
$40K |
| 73030 |
|
907 |
792 |
$40K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
166 |
137 |
$39K |
| 99215 |
Prolong outpt/office vis |
525 |
432 |
$38K |
| 80306 |
|
1,857 |
1,561 |
$36K |
| 87430 |
|
2,555 |
2,421 |
$36K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,722 |
5,047 |
$34K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
251 |
233 |
$34K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,674 |
4,839 |
$32K |
| 83880 |
|
1,126 |
1,012 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
636 |
572 |
$29K |
| 97597 |
|
2,210 |
967 |
$28K |
| 84702 |
|
2,615 |
2,082 |
$27K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
821 |
724 |
$26K |
| J3490 |
Unclassified drugs |
3,012 |
2,456 |
$24K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
394 |
214 |
$23K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
554 |
487 |
$23K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,331 |
968 |
$22K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,346 |
893 |
$22K |
| 73564 |
|
520 |
439 |
$21K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
194 |
170 |
$21K |
| 73110 |
|
452 |
401 |
$21K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
514 |
473 |
$19K |
| 87210 |
|
4,032 |
3,603 |
$19K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
292 |
210 |
$18K |
| 84703 |
|
1,799 |
1,585 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
629 |
595 |
$17K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,232 |
2,781 |
$16K |
| 87081 |
|
2,297 |
2,149 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,302 |
2,076 |
$15K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,830 |
1,602 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,767 |
1,492 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,618 |
1,436 |
$13K |
| 82728 |
|
1,263 |
1,163 |
$13K |
| 73560 |
|
287 |
254 |
$12K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,067 |
1,698 |
$12K |
| 72100 |
|
277 |
240 |
$10K |
| 96376 |
|
331 |
233 |
$10K |
| 81003 |
|
3,899 |
3,462 |
$9K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,854 |
1,715 |
$9K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,488 |
1,305 |
$9K |
| 93971 |
|
128 |
107 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,052 |
940 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
159 |
107 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
1,193 |
1,041 |
$7K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
310 |
290 |
$7K |
| 83550 |
|
944 |
874 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,248 |
983 |
$6K |
| 90715 |
|
161 |
139 |
$6K |
| 87420 |
|
440 |
418 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
453 |
391 |
$6K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
445 |
386 |
$5K |
| A0425 |
Ground mileage, per statute mile |
3,401 |
2,560 |
$5K |
| 83540 |
|
956 |
886 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
460 |
414 |
$5K |
| 86901 |
|
1,251 |
1,090 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
115 |
106 |
$4K |
| 85379 |
|
301 |
277 |
$3K |
| 84439 |
|
345 |
295 |
$3K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
58 |
42 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
524 |
468 |
$3K |
| G0378 |
Hospital observation service, per hour |
190 |
128 |
$3K |
| 83605 |
|
315 |
281 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
477 |
412 |
$3K |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
472 |
388 |
$3K |
| 87088 |
|
316 |
281 |
$3K |
| 82575 |
|
495 |
226 |
$3K |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
110 |
102 |
$3K |
| 12001 |
|
80 |
74 |
$2K |
| 73502 |
|
87 |
77 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
313 |
239 |
$2K |
| 73590 |
|
40 |
37 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
197 |
163 |
$2K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
136 |
87 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,487 |
1,561 |
$2K |
| 73140 |
|
43 |
43 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
375 |
322 |
$2K |
| 11045 |
|
14 |
12 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
338 |
302 |
$2K |
| 87040 |
|
162 |
98 |
$1K |
| 80051 |
|
185 |
177 |
$1K |
| 74018 |
|
31 |
28 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
315 |
282 |
$1K |
| 97598 |
|
44 |
26 |
$1K |
| 73080 |
|
30 |
27 |
$1K |
| 76642 |
|
61 |
55 |
$1K |
| 96415 |
|
80 |
55 |
$1K |
| 10060 |
|
33 |
29 |
$1K |
| 84156 |
|
497 |
226 |
$1K |
| 80061 |
Lipid panel |
72 |
68 |
$1K |
| A4565 |
Slings |
253 |
225 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
127 |
114 |
$970.64 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
94 |
84 |
$867.65 |
| 82378 |
|
58 |
53 |
$775.70 |
| 87186 |
|
89 |
79 |
$729.06 |
| 85610 |
|
242 |
202 |
$693.62 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13 |
13 |
$666.09 |
| 73090 |
|
14 |
12 |
$611.76 |
| 96417 |
|
21 |
12 |
$547.97 |
| 85730 |
|
120 |
101 |
$538.61 |
| 29125 |
|
26 |
24 |
$504.51 |
| 72040 |
|
15 |
12 |
$502.03 |
| 80320 |
|
149 |
118 |
$447.84 |
| 82565 |
|
164 |
158 |
$373.84 |
| V2632 |
Posterior chamber intraocular lens |
65 |
31 |
$359.00 |
| 84520 |
|
150 |
146 |
$336.71 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
26 |
12 |
$315.14 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
53 |
52 |
$311.24 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
31 |
25 |
$269.82 |
| 29505 |
|
13 |
13 |
$179.89 |
| A0398 |
Als routine disposable supplies |
190 |
135 |
$160.06 |
| 86900 |
|
43 |
37 |
$156.44 |
| 87070 |
|
42 |
36 |
$138.92 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
16 |
12 |
$133.00 |
| 83883 |
|
12 |
12 |
$129.28 |
| 82310 |
|
12 |
12 |
$82.44 |
| 82784 |
|
13 |
13 |
$81.20 |
| 87205 |
|
42 |
36 |
$68.95 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
63 |
30 |
$59.85 |
| 85027 |
|
20 |
12 |
$59.29 |
| 84165 |
|
14 |
14 |
$52.78 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
47 |
29 |
$48.40 |
| 84460 |
|
134 |
130 |
$42.71 |
| 84100 |
|
25 |
25 |
$41.37 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
62 |
29 |
$35.20 |
| 96523 |
|
27 |
24 |
$22.53 |
| 82947 |
|
119 |
117 |
$6.81 |